CAMBRIDGE, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced that its presentation at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com.
During the presentation, Dr. Deborah Dunsire, president and chief executive officer, and Marsha Fanucci, chief financial officer and senior vice president, corporate strategy, will discuss the Company's 2007 financial results as well as goals and financial guidance for 2008. The presentation will be delivered at 8:00 a.m. ET on Thursday, February 7, 2008 from The Grand Hyatt Hotel in New York, NY. The presentation will be archived for 30 days.
Before the presentation on February 7, 2008, the Company's 2007 year-end financial results will be issued in a press release.
Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortezomib) for Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in two therapeutic areas: oncology and inflammation. By applying its knowledge of the human genome, understanding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Company's website is http://www.millennium.com.
Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com.
|SOURCE Millennium Pharmaceuticals, Inc.|
Copyright©2008 PR Newswire.
All rights reserved